Literature DB >> 11854102

Palliative care in amyotrophic lateral sclerosis.

G D Borasio1, R Voltz, R G Miller.   

Abstract

Amyotrophic lateral sclerosis (ALS) is the most common degenerative motor neuron disease in adults. The clinical picture consists of generalized fasciculations, progressive atrophy and weakness of the skeletal muscles, spasticity and pyramidal tract signs, dysarthria, dysphagia, and dyspnea. Pseudobulbar affect is common. Disease-specific treatment options are still unsatisfactory. Therapeutic nihilism is not justified as a large array of palliative measures available to enhance the quality of life of patients and their families. Because of its clinical characteristics, ALS represents a paradigm for palliative care in neurological diseases. Numerous projects are being undertaken worldwide in an effort to enlarge the evidence base for palliative interventions in ALS. Palliative care in ALS is a multidisciplinary effort requiring careful coordination. An open and empathic disclosure of the diagnosis is essential. Nutritional deficiency caused by dysphagia can be relieved by a percutaneous endoscopic gastrostomy. Respiratory insufficiency can be effectively treated by non-invasive home mechanical ventilation. The terminal phase of the disease should be discussed at the latest when symptoms of dyspnea appear, in order to prevent unwarranted fears of "choking to death." Psychological and spiritual care of patients and families are important. Collaboration with hospice institutions and completion of advance directives can be of invaluable help in the terminal phase.

Entities:  

Mesh:

Year:  2001        PMID: 11854102     DOI: 10.1016/s0733-8619(05)70049-9

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  20 in total

1.  Riluzole treatment in advanced ALS.

Authors:  Gian Domenico Borasio
Journal:  J Neurol       Date:  2002-05       Impact factor: 4.849

Review 2.  Management of motor neurone disease.

Authors:  R S Howard; R W Orrell
Journal:  Postgrad Med J       Date:  2002-12       Impact factor: 2.401

Review 3.  Percutaneous endoscopic gastrostomy: a safe and effective bridge for enteral nutrition in neurological or non-neurological conditions.

Authors:  Rasim Gencosmanoglu
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

Review 4.  The role of palliative care in patients with neurological diseases.

Authors:  Gian Domenico Borasio
Journal:  Nat Rev Neurol       Date:  2013-04-02       Impact factor: 42.937

5.  [Amyotrophic lateral sclerosis--when planning is almost too late].

Authors:  Veronika Praxmarer; Heinz Lahrmann
Journal:  Wien Med Wochenschr       Date:  2006-05

Review 6.  Drug therapy for pain in amyotrophic lateral sclerosis or motor neuron disease.

Authors:  Johannes Brettschneider; Jerome Kurent; Albert Ludolph
Journal:  Cochrane Database Syst Rev       Date:  2013-06-05

7.  [Amyotrophic lateral sclerosis: management of bulbar symptoms].

Authors:  P Kraft; M Beck; A Grimm; C Wessig; K Reiners; K V Toyka
Journal:  Nervenarzt       Date:  2010-10       Impact factor: 1.214

8.  Outcome of ventilatory support for acute respiratory failure in motor neurone disease.

Authors:  M D Bradley; R W Orrell; J Clarke; A C Davidson; A J Williams; D M Kullmann; N Hirsch; R S Howard
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-06       Impact factor: 10.154

Review 9.  The management of amyotrophic lateral sclerosis.

Authors:  Julie Phukan; Orla Hardiman
Journal:  J Neurol       Date:  2009-02-17       Impact factor: 4.849

10.  Mushroom-cage gastrostomy tube placement in patients with amyotrophic lateral sclerosis: a 5-year experience in 104 patients in a single institution.

Authors:  Dylan Lewis; Mary-Ann Ampong; Alan Rio; Emma Willey; Julia Johnson; Christopher E Shaw; Catherine M Ellis; Ammar Al-Chalabi; P Nigel Leigh; Paul S Sidhu
Journal:  Eur Radiol       Date:  2009-02-04       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.